South & Central America Smart Life Sciences Manufacturing Market Forecast to 2033

South & Central America Smart Life Sciences Manufacturing Market Forecast to 2033 – Regional Analysis – by Component (Solutions and Services), Technology [AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and Others], and Application (Pharma, Bio-Pharma, and Medical Device)

Send Enquiry

$2,100$3,500

Description

The South & Central America Smart Life sciences manufacturing market is expected to grow from US$ 1,574.98 million in 2023 to US$ 5,285.77 million by 2033. It is estimated to grow at a CAGR of 12.9% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel South & Central America Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.

Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company’s departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes’ sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British–Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.

South & Central America Smart Life Sciences Manufacturing Market Overview

The smart life sciences manufacturing market in South America is segmented into Brazil, Argentina, and the rest of South America. The region is expected to develop moderately over the period owing to the positive influence of North American countries. South America is expected to have regulatory policies for the use and approval of medical devices, pharmaceuticals, and other life science products. The medical device market in Brazil is governed by the Brazilian Health Regulatory Agency, ANVISA. The ANVISA came up with a new resolution, RDC 687/2022, to grant or renew the Brazilian Good Manufacturing Practice (BGMP) certification for medical devices and is in effect from June 01, 2022, annulling RDC 183/2017. RDC 183 was published in 2017 to modernize and accelerate the process of issuing GMP certificates. The Resolution RDC no. 687 was published on May 13, 2022, to simplify the documentation required for GMP certification. It brings down the technical requirements for the certification, which gives great momentum to the certification process. Furthermore, manufacturers from the US, Canada, and other neighboring countries are expanding into countries in South America, and the manufacturers are focused on setting the smart manufacturing facilities, which will help in the long run. In May 2022, Johnson & Johnson South America partnered with Microsoft for business transformation by embedding intelligent automation into the organization. The opportunity to reimagine work is significant and has the potential to empower and equip employees with new skills; capabilities; and the freedom to focus on fulfilling, engaging, and purpose-driven work. Therefore, all the above-mentioned factors are expected to accelerate the smart life sciences manufacturing market growth in South America in the coming years.

South & Central America Smart Life Sciences Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Smart Life Sciences Manufacturing Market Segmentation

The South & Central America smart life sciences manufacturing market is segmented into technology, component, application, and country.

Based on component, the South & Central America smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the South & Central America smart life sciences manufacturing market in 2023.

Based on technology segment is categorized into AR/VR Systems, Internet of things (IOT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of things segment held a largest share of the South & Central America smart life sciences manufacturing market in 2023. Further, the cybersecurity segment is categorized into IT cybersecurity and OT cybersecurity.

Based on Application, the South & Central America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The pharma segment held the largest share of the South & Central America smart life sciences manufacturing market in 2023.

Based on country, the South & Central America smart life sciences manufacturing market is segmented into Argentina, Brazil, and the Rest of South & Central America. Brazil dominated the South & Central America smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the South & Central America smart life sciences manufacturing market.

Summary Info

Industry:

,

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 12.9% CAGR, the South & Central America Smart Life Sciences Manufacturing Market is speculated to be worth US$ 5,285.77 million by 2033, saysthe research team

According tothe research team’ research, the South & Central America smart life sciences manufacturing market was valued at US$ 1,574.98 million in 2023 and is expected to reach US$ 5,285.77 million by 2033, registering a CAGR of 12.9% from 2023 to 2033. Rising adoption of Pharma 4.0 and increasing use of technologies in biotechnology laboratories are the critical factors attributed to the South & Central America smart life sciences manufacturing market.

Pharma 4.0, the fourth industrial revolution, is a holistic approach to the manufacturing of medicinal products. It was introduced by the International Society for Pharmaceutical Engineering (ISPE) in 2017. Advanced automation solutions, modern cloud-based manufacturing execution systems, augmented reality (AR), and cybersecurity are among the major aspects of Pharma 4.0. The goal of Pharma 4.0 is to achieve safer pharmaceutical production with greater efficiency along the whole value chain. It is a highly efficient automated process driven by an integrated manufacturing control strategy.

Artificial intelligence (AI), big data, and machine learning (ML) technologies contribute to highly integrated and autonomous manufacturing systems. The COVID-19 pandemic underlined the insufficiency of paper-based processes in the manufacturing sector across the world. Companies in this sector are looking for having real-time visibility into production processes. The pharmaceutical industry has noticed improvements after the implementation of digital and automation technologies. Many examples have been found in which the process is quite free flow after companies adopting Pharma 4.0.

Novartis AG, Pfizer Inc, Eli Lilly, Cipla, and Galderma are among the well-known life sciences companies adopting Pharma 4.0. In December 2019, Amazon Web Services (AWS) entered into a strategic collaboration with Novartis. As part of this collaboration, Novartis intended to leverage AWS’s broadest portfolio of cloud services to build an enterprise-wide data and analytics platform to transform its business operations. The primary aim of the collaboration was to enable real-time analytics, make better business decisions, and increase efficiencies across manufacturing processes and supply chains. Additionally, single-use bioprocessing requires low maintenance and has lower operational expenditures. This signifies all biotechnology companies are expected to invest heavily in automation and modern analytics technologies to build technologically advanced smart factories.

The pharmaceutical segment is a key contributor to the industrial sector. Moreover, the demand and sales of medicine are increasing every day. Thus, pharmaceutical manufacturing businesses invest huge amounts of economic resources in R&D for bringing innovations to markets. Technology upgrades are the key to tackling future manufacturing problems.

Thus, the growing adoption of Pharma 4.0 is a key factor driving the progression of the smart life sciences manufacturing market.

On the contrary, presence of skill gap and need for high initial investment hampers the South & Central America smart life sciences manufacturing market.

Based on component, the South & Central America smart life sciences manufacturing market is bifurcated into solutions and services. The solutions segment held 71.0% share of South & Central America smart life sciences manufacturing market in 2023, amassing US$ 1,117.67 million. It is projected to garner US$ 3,623.26 million by 2033 to expand at 12.5% CAGR during 2023–2033.

Based on technology, the South & Central America smart life sciences manufacturing market is segmented into AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things (IoT) segment held 60.6% share of South & Central America smart life sciences manufacturing market in 2023, amassing US$ 954.05 million. It is projected to garner US$ 2,972.04 million by 2033 to expand at 12.0% CAGR during 2023–2033.

Based on type, the South & Central America smart life sciences manufacturing market is bifurcated into IT Cybersecurity, and OT Cybersecurity. The OT Cybersecurity segment held 52.5% share of South & Central America smart life sciences manufacturing market in 2023, amassing US$ 186.50 million. It is projected to garner US$ 679.31 million by 2033 to expand at 13.8% CAGR during 2023–2033.

Based on application, the South & Central America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical device. The pharma segment held 44.9% share of South & Central America smart life sciences manufacturing market in 2023, amassing US$ 706.80 million. It is projected to garner US$ 2,228.07 million by 2033 to expand at 12.2% CAGR during 2023–2033.

Based on country, the South & Central America smart life sciences manufacturing market has been categorized into Argentina, Brazil, and the Rest of South & Central America. Our regional analysis states that the Brazil captured 55.2% share of South & Central America smart life sciences manufacturing market in 2023. It was assessed at US$ 868.92 million in 2023 and is likely to hit US$ 3,030.33 million by 2033, exhibiting a CAGR of 13.3% during the forecast period.

Key players operating the South & Central America smart life sciences manufacturing market are ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Smart Life Sciences Manufacturing Market – By Component
1.3.2 South & Central America Smart Life Sciences Manufacturing Market – By Technology
1.3.3 South & Central America Smart Life Sciences Manufacturing Market – By Application
1.3.4 South & Central America Smart Life Sciences Manufacturing Market – By Country
2. Smart Life Sciences Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Smart Life Sciences Manufacturing Market – Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion
5. Smart Life Sciences Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Pharma 4.0
5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
5.3.1 Use of Artificial Intelligence in Cancer Research
5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
5.4.1 Connection to Data Silos
5.4.2 Usage of Blockchain
5.4.3 Edge Computing
5.4.4 Predictive Maintenance
5.4.5 Vision-Based Quality Management
5.4.6 Smart Factory Trends
5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints
6. Smart Life Sciences Manufacturing Market – South & Central America Analysis
6.1 Overview
6.2 Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
7. Smart Life Sciences Manufacturing Market Analysis – By Component
7.1 Overview
7.2 Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
7.3.1 Overview
7.3.2 Solutions: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
7.4.1 Overview
7.4.2 Services: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8. Smart Life Sciences Manufacturing Market Analysis – By Technology
8.1 Overview
8.2 Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
8.3.1 Overview
8.3.2 AR/VR System: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
8.4.1 Overview
8.4.2 Internet of Things (IOT): Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
8.5.1 Overview
8.5.2 Artificial Intelligence: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
8.6.1 Overview
8.6.2 Cyber Security: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
8.7.1 Overview
8.7.2 Big Data: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9. Smart Life Sciences Manufacturing Market Analysis – By Application
9.1 Overview
9.2 Smart Life Sciences Manufacturing Market, by Application (2022 and 2033)
9.3 Pharma
9.3.1 Overview
9.3.2 Pharma: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9.4 BioPharma
9.4.1 Overview
9.4.2 Biopharma: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
9.5.1 Overview
9.5.2 Medical Device: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
10. Smart Life Sciences Manufacturing Market Analysis – By Country
10.1 South America: Smart Life Sciences Manufacturing Market Overview
10.1.1. Brazil: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.1 Overview
10.1.1.2 Brazil: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.3 Brazil: Smart Life Sciences Manufacturing Market, by Component, 2022–2033 (US$ Million)
10.1.1.4 Brazil: Smart Life Sciences Manufacturing Market, by Technology, 2022–2033 (US$ Million)
10.1.1.4.1 Brazil: Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022–2033 (US$ Million)
10.1.1.5 Brazil: Smart Life Sciences Manufacturing Market, by Application, 2022–2033 (US$ Million)
10.1.2 Argentina: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.2.1 Overview
10.1.2.2 Argentina: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.2.3 Argentina: Smart Life Sciences Manufacturing Market, by Component, 2022–2033 (US$ Million)
10.1.2.4 Argentina: Smart Life Sciences Manufacturing Market, by Technology, 2022–2033 (US$ Million)
10.1.2.4.1 Argentina: Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022–2033 (US$ Million)
10.1.2.5 Argentina: Smart Life Sciences Manufacturing Market, by Application, 2022–2033 (US$ Million)
10.1.3 Rest of South America: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.3.1 Overview
10.1.3.2 Rest of South America: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.3.3 Rest of South America: Smart Life Sciences Manufacturing Market, by Component, 2022–2033 (US$ Million)
10.1.3.4 Rest of South America: Smart Life Sciences Manufacturing Market, by Technology, 2022–2033 (US$ Million)
10.1.3.4.1 Rest of South America: Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022–2033 (US$ Million)
10.1.3.5 Rest of South America: Smart Life Sciences Manufacturing Market, by Application, 2022–2033 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures
12. Company Profile
12.1 ABB Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bosch Rexroth AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Emerson Electric Co
12.3.1 Business Description
12.3.2 Products and Services
12.3.3 Financial Overview
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 Fortinet Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric Co
12.5.1 Business Description
12.5.2 Products and Services
12.5.3 Financial Overview
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Honeywell International Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 International Business Machines Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rockwell Automation Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Siemens AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Sophos Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Word Index

LIST OF TABLES

Table 1. Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Table 2. Brazil Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 3. Brazil Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 4. Brazil Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 5. Brazil Smart Life Sciences Manufacturing Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 6. Argentina Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 7. Argentina Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 8. Argentina Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 9. Argentina Smart Life Sciences Manufacturing Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 10. Rest of South America Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 11. Rest of South America Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 12. Rest of South America Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 13. Rest of South America Smart Life Sciences Manufacturing Market, by Application – Revenue and Forecast to 2033 (US$ Million)
Table 14. List of Abbreviation

LIST OF FIGURES

Figure 1. South & Central America Smart Life Sciences Manufacturing Market Segmentation
Figure 2. Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. South & Central America Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in Smart Life Sciences Manufacturing Market
Figure 5. Internet of Things (IoT) Held Largest Share of Technology Segment in Smart Life Sciences Manufacturing Market
Figure 6. South & Central America Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. South & Central America: PEST Analysis
Figure 8. Expert Opinion
Figure 1. Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 2. Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 3. Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 4. Solutions: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 5. Services: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 6. Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 7. AR/VR System: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 8. Internet of Things (IOT): Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 9. Artificial Intelligence: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 10. Cyber Security: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 11. Big Data: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Others: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 13. Smart Life Sciences Manufacturing Market Revenue Share, By Application (2022 and 2033)
Figure 14. Pharma: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Bio-Pharma: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Medical Device: Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 17. South America Smart Life Sciences Manufacturing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 18. South & Central America Smart Life Sciences Manufacturing Market Revenue Share, by Key Country, (2022 & 2033)
Figure 19. Brazil: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 20. Argentina: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 21. Rest of South America: Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)

The List of Companies – South & Central America Smart Life Sciences Manufacturing Market

– ABB Ltd
– Bosch Rexroth AG
– Emerson Electric Co
– Fortinet Inc
– General Electric CO
– Honeywell International Inc
– International Business Machines Corp
– Rockwell Automation Inc
– Siemens AG
– Sophos Ltd

Reviews

There are no reviews yet.

Be the first to review “South & Central America Smart Life Sciences Manufacturing Market Forecast to 2033”